Statements (44)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:abbreviation |
gptkb:NSAID
|
gptkbp:activeIngredient |
gptkb:diclofenac_sodium
|
gptkbp:affiliatedWith |
nonsteroidal anti-inflammatory drug
|
gptkbp:approvedBy |
1970s
|
gptkbp:ATCCode |
gptkb:M01AB05
|
gptkbp:availableOn |
many countries worldwide
|
gptkbp:brand |
gptkb:diclofenac
|
gptkbp:contraindication |
asthma
peptic ulcer hypersensitivity to NSAIDs severe heart failure |
gptkbp:effect |
reduces pain and inflammation
reduces prostaglandin synthesis |
gptkbp:form |
gptkb:tablet
injection gel topical solution suppository |
gptkbp:genericAvailable |
yes
|
https://www.w3.org/2000/01/rdf-schema#label |
Voltaren
|
gptkbp:legalStatus |
over-the-counter (topical, in some countries)
prescription only (in some countries) |
gptkbp:manufacturer |
gptkb:Novartis
GlaxoSmithKline |
gptkbp:mechanismOfAction |
inhibits cyclooxygenase (COX) enzymes
|
gptkbp:pregnancyCategory |
varies by country
|
gptkbp:routeOfAdministration |
oral
topical intramuscular rectal |
gptkbp:sideEffect |
nausea
dizziness headache rash gastrointestinal upset |
gptkbp:storage |
room temperature
|
gptkbp:usedFor |
osteoarthritis
pain relief inflammation rheumatoid arthritis ankylosing spondylitis |
gptkbp:bfsParent |
gptkb:Novartis
|
gptkbp:bfsLayer |
4
|